On October 7th the EU Commission published its updated study on corruption in the EU healthcare sector. In this article, Baker McKenzie suggests that companies in the healthcare industry should rethink their policies and procedures based on the results of this Europe-wide study. The study covered all EU Member States but focused on Croatia, Greece, Hungary, Lithuania, Poland, and Romania.
Relevant finding for companies in the sector were that –
- bribery in medical service delivery remains one of the main challenges, especially in many Eastern and Southern European Member States;
- transparent procedures are key in addressing corruption in procurement processes; and
- attempts to address improper marketing increase at both EU and national level.
The study identified 6 typologies of corruption –
- bribery in medical service delivery;
- procurement corruption;
- improper marketing relations;
- misuse of (high) level positions;
- undue reimbursement claims; and
- fraud and embezzlement of medicines and medical devices.